We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

By LabMedica International staff writers
Posted on 06 Aug 2025

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. More...

However, IMS is hindered by relatively low spatial resolution and a lack of cellular morphological detail—both of which are crucial for accurately interpreting molecular profiles within the structural context of tissue.

Conventional workflows also rely on labor-intensive chemical staining and complex image registration, which consume time and compromise tissue integrity. Now, a novel diffusion-based virtual staining approach can transform low-resolution IMS data into high-resolution histological images, improving the clarity of tissue structure without sacrificing the original sample.

The artificial intelligence (AI)-based technique developed by an international team of researchers from the University of California, Los Angeles (UCLA, Los Angeles, CA, USA), Vanderbilt University (Nashville, TN, USA) and Delft University of Technology (TU Delft, Delft, Netherlands) uses a diffusion-based generative model to virtually stain label-free IMS images. This model digitally produces images that closely resemble traditional histochemical staining—particularly Periodic Acid-Schiff (PAS) staining, which highlights polysaccharides, glycoproteins, and mucins—despite the original IMS data having pixel sizes nearly ten times larger than those of optical microscopy.

By optimizing the noise sampling process during AI inference, the researchers enhanced the reliability and consistency of the virtual staining. The method allows the digital transformation of IMS data into high-resolution brightfield microscopy images, eliminating the need for chemical staining and preserving tissue samples for further molecular analysis.

The research team tested the solution in blind evaluations on human kidney tissues, where the virtually stained images successfully enabled pathologists to identify critical renal structures and disease features with accuracy comparable to conventional stained images. The results, published in Nature Communications, show that the technique significantly improves the interpretability of IMS data and holds potential for widespread clinical and research applications.

By virtually introducing microscopic-level histological detail, the method supports IMS-driven molecular histology while streamlining workflows. The researchers anticipate that their AI-driven approach will open new possibilities in spatial biology and clinical diagnostics and plan to expand its use across other tissue types and staining modalities.

“This diffusion-based approach dramatically enhances the interpretability of mass spectrometry images. It virtually introduces microscopic-level histological detail, bridging the gap between molecular specificity and cellular morphology, all without chemically staining the tissue,” said Professor Aydogan Ozcan, corresponding author at UCLA.

Related Links:
UCLA 
Vanderbilt University
TU Delft


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Immunofluorescence Analyzer
IFA System
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.